Skip to main content
TipRanks
Go Ultimate75% OFF

PanGenomic Health, Inc. Class A (NARA) Stock Price & Analysis

33 Followers

NARA Stock Chart & Stats

CA$0.30CA$0.00(0.00%)
At close: 4:00 PM EST
C$0.2C$0.3C$0.4Aug 12Aug 24Sep 11Sep 14Oct 5Oct 23Nov 4
Day’s Range
CAD 0.25 - CAD 0.30
52-Week Range
CAD 0.16 - CAD 1.00
Previous Close
CAD 0.30
Volume
N/A
Average Volume (3M)
617
Market Cap
CAD 4.21M
Enterprise Value
CAD 10.18M
Total Cash (Recent Filing)
CAD 7,717
Total Debt (Recent Filing)
CAD 715.34K
Price to Earnings (P/E)
―
Beta
-0.00
Next Earnings
Nov 26, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Moderate Absolute Debt

Debt remains moderate in absolute dollar terms and has not been consistently high across every year. This provides some balance-sheet support relative to a more heavily indebted structure, although negative equity still limits financial flexibility and makes external funding important.

Cash Flow Tracks Reported Losses

Free cash flow broadly tracking net income suggests reported losses are not being heavily obscured by non-cash accounting items. That alignment improves transparency around the company’s cash economics, even though the underlying cash outflows remain substantial and persistent.

Losses Reflect Operating Investment

Losses appear connected to operating investment rather than unstable revenue movements, which may indicate spending to develop the business rather than sharp sales volatility. The potential benefit is a clearer path to operating leverage if those investments eventually produce commercial activity.

Bears Say

Pre-revenue Business

The absence of reported revenue means the business has not yet demonstrated commercial traction or a functioning sales engine. Consistently negative gross profit further indicates that the core offering is not currently covering direct costs, leaving future viability dependent on achieving meaningful sales.

Widening Net Losses

Net losses have widened materially into the TTM period, showing that operating costs are increasing faster than the company’s ability to generate earnings. Persistent deterioration raises the amount of capital required to reach profitability and reduces confidence in near-term earnings self-sufficiency.

Persistent Cash Burn

Ongoing negative operating and free cash flow shows that the company is not self-funding its operations. Continued cash burn can consume financial resources, increase reliance on external financing, and make it harder to sustain development or absorb delays in achieving revenue.

PanGenomic Health, Inc. Class A News

NARA FAQ

What was PanGenomic Health, Inc. Class A’s price range in the past 12 months?
PanGenomic Health, Inc. Class A lowest stock price was C$0.16 and its highest was C$1.00 in the past 12 months.
What is PanGenomic Health, Inc. Class A’s market cap?
PanGenomic Health, Inc. Class A’s market cap is C$4.21M.
When is PanGenomic Health, Inc. Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PanGenomic Health, Inc. Class A’s earnings last quarter?
PanGenomic Health, Inc. Class A released its earnings results on Aug 31, 2026. The company reported -C$0.027 earnings per share for the quarter.
Is PanGenomic Health, Inc. Class A overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PanGenomic Health, Inc. Class A pay dividends?
PanGenomic Health, Inc. Class A does not currently pay dividends.
What is PanGenomic Health, Inc. Class A’s EPS estimate?
PanGenomic Health, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PanGenomic Health, Inc. Class A have?
PanGenomic Health, Inc. Class A has 14,046,870 shares outstanding.
What happened to PanGenomic Health, Inc. Class A’s price movement after its last earnings report?
PanGenomic Health, Inc. Class A reported an EPS of -C$0.027 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PanGenomic Health, Inc. Class A?
Currently, no hedge funds are holding shares in TSE:NARA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology